Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Epinephrine now available in a nasal spray formulation (neffy) is being hailed as a way to diminish barriers to use ...

The Food and Drug Administration approved a nasal spray intended to treat severe allergic reactions on Friday, expanding options beyond needle-based treatments like the EpiPen. The nasal spray ...

And it may look familiar. It’s a similar design to a naloxone or Narcan spray. All you need to do is put it in your nose and ...

The U.S. Food and Drug Administration has approved ARS Pharmaceuticals' nasal spray as the first needle-free emergency treatment for potentially fatal allergic reactions. REUTERS The U.S. Food ...

Federal health regulators approved the first no-shot device that treats potentially deadly allergic reactions using a nasal ...

Similarly, the South African market is also experiencing an influx of convenience-focused allergy care products, specifically ...

The U.S. Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as anaphylaxis, providing a needle-free alternative to EpiPens and similar ...

Rahul Sidhu does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

Support us to deliver journalism without an agenda. On 9 August, US health officials approved the first nasal spray to treat allergic reactions from drugmaker ARS Pharmaceuticals Inc, an ...

Give as single spray intranasally into one nostril. May give additional doses (using a new nasal spray) every 2–3mins in alternate nostrils if unresponsive or relapses into respiratory depression.